↓ Skip to main content

Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial

Overview of attention for article published in Lancet Oncology, September 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

news
1 news outlet
twitter
33 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial
Published in
Lancet Oncology, September 2019
DOI 10.1016/s1470-2045(19)30319-5
Pubmed ID
Authors

Silvia Stacchiotti, Stefano Ferrari, Andres Redondo, Nadia Hindi, Emanuela Palmerini, Maria Angeles Vaz Salgado, Anna Maria Frezza, Paolo Giovanni Casali, Antonio Gutierrez, Antonio Lopez-Pousa, Giovanni Grignani, Antoine Italiano, Axel LeCesne, Sarah Dumont, Jean Yves Blay, Nicolas Penel, Daniel Bernabeu, Enrique de Alava, Marie Karanian, Carlo Morosi, Silvia Brich, Gian Paolo Dagrada, Viviana Vallacchi, Chiara Castelli, Monica Brenca, Dominga Racanelli, Roberta Maestro, Paola Collini, Josefina Cruz, Javier Martin-Broto

Twitter Demographics

The data shown below were collected from the profiles of 33 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 50%
Student > Doctoral Student 1 13%
Student > Ph. D. Student 1 13%
Student > Bachelor 1 13%
Unspecified 1 13%
Other 0 0%
Readers by discipline Count As %
Medicine and Dentistry 5 63%
Unspecified 2 25%
Biochemistry, Genetics and Molecular Biology 1 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 October 2019.
All research outputs
#572,511
of 13,757,952 outputs
Outputs from Lancet Oncology
#753
of 4,936 outputs
Outputs of similar age
#18,371
of 248,994 outputs
Outputs of similar age from Lancet Oncology
#32
of 126 outputs
Altmetric has tracked 13,757,952 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,936 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.2. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 248,994 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 126 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.